Roslyn Boyd is a physiotherapist with a background in neuroscience, biomechanics and rehabilitation. She is recognised internationally for her clinical trials of Botulinum toxin A (for hip displacement, upper limb rehabilitation), randomised trials of upper limb neurorehabilitation children with congenital hemiplegia and developmental care at home for infants born preterm.

The current focus of Roslyn’s research is examining the relationship between early motor development and brain structure and function, the nature of the white matter injury, the response to novel rehabilitation and outcomes of population based cohorts of children with cerebral palsy.

In all she has been a leader of 5 RCT’s, worked as part of team to develop a condition specific HRQOL measure, and has achieved over AU$5.4Sm in research funding. She now leads a new research team at the Royal Children’s Hospital Brisbane with 60FTE clinicians in the Dept of Rehabilitation within the School of Medicine at the University of Queensland .

In 2004 A/Professor Boyd became the first Allied Health recipient of a Victorian Premiers Commendation for Medical Research, in 2007 a Smart State Fellowship award by the Queensland Minister for State Development. She has been a past chair of the Research and Awards committee of the American Academy of Cerebral Palsy and Developmental Medicine. Roslyn is the Scientific convenor of the 3 rd International Cerebral palsy conference and has developed the program to draw together many of the international leaders in cerebral palsy research.